Edap Tms (NASDAQ:EDAP) Downgraded by StockNews.com to Sell

StockNews.com cut shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a research report sent to investors on Friday morning.

Separately, HC Wainwright raised their price objective on shares of Edap Tms from $16.00 to $19.00 and gave the stock a buy rating in a research note on Monday, April 1st.

Edap Tms Stock Down 2.7 %

Shares of EDAP opened at $7.14 on Friday. The company has a quick ratio of 2.30, a current ratio of 2.84 and a debt-to-equity ratio of 0.04. The business has a fifty day moving average of $7.34 and a 200 day moving average of $6.29. The company has a market cap of $264.89 million, a PE ratio of -11.33 and a beta of 0.65. Edap Tms has a 52-week low of $3.60 and a 52-week high of $12.23.

Edap Tms (NASDAQ:EDAP) last announced its earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.13). Edap Tms had a negative net margin of 35.03% and a negative return on equity of 34.33%. The firm had revenue of $21.27 million during the quarter, compared to analysts’ expectations of $21.30 million. On average, sell-side analysts expect that Edap Tms will post -0.36 EPS for the current year.

Institutional Trading of Edap Tms

Large investors have recently made changes to their positions in the stock. Milestone Investment Advisors LLC purchased a new position in Edap Tms in the 3rd quarter worth about $39,000. Summit Trail Advisors LLC bought a new position in Edap Tms in the 3rd quarter worth about $77,000. Miracle Mile Advisors LLC purchased a new position in shares of Edap Tms during the first quarter worth approximately $136,000. Finally, Rock Springs Capital Management LP raised its stake in shares of Edap Tms by 14.6% during the third quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock valued at $9,547,000 after acquiring an additional 173,700 shares in the last quarter. 62.74% of the stock is owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.